Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$65.7K Buy
546
+91
+20% +$10.5K 0.02% 267
2025
Q4
$47.9K Buy
455
+36
+9% +$3.38K 0.01% 280
2025
Q3
$35.2K Buy
419
+190
+83% +$15.6K 0.01% 296
2025
Q2
$18.1K Sell
229
-111
-33% -$8.82K 0.01% 347
2025
Q1
$30.6K Sell
340
-28
-8% -$2.61K 0.01% 242
2024
Q4
$36.6K Sell
368
-514
-58% -$53K 0.02% 209
2024
Q3
$100K Buy
882
+251
+40% +$29.8K 0.05% 121
2024
Q2
$78.1K Buy
631
+56
+10% +$7.21K 0.05% 115
2024
Q1
$75.9K Buy
575
+43
+8% +$5.3K 0.06% 87
2023
Q4
$58K Buy
+532
New +$55.2K 0.05% 87

Other funds holding MRK

Dunhill Financial's MRK Position: Q1 2026 in Review

Dunhill Financial increased its Merck (MRK) stake by 20% in Q1 2026, buying an estimated $10.5K and bringing the position to 546 shares worth $65.7K. The position accounts for 0.02% of the portfolio, ranked #267.

Dunhill Financial first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. The position peaked at $100K in Q3 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Dunhill Financial held 546 shares of Merck worth $65.7K as of Q1 2026.
  • Dunhill Financial bought 91 Merck shares in Q1 2026, an estimated $10.5K.
  • Merck made up 0.02% of Dunhill Financial's portfolio in Q1 2026, its #267 holding.
  • Dunhill Financial first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
  • Dunhill Financial's Merck position peaked at $100K in Q3 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Dunhill Financial's 13F filing for Q1 2026, filed 6 May 2026.